Effects of anxiety on cardiometabolic health
Journal of the American Heart Association Jan 27, 2022
NOTE, original article title: Neuroticism, worry, and cardiometabolic risk trajectories: Findings from a 40‐year study of men
Given an uncertainty regarding the mechanisms involved in the correlation between anxiety and elevated risk of cardiometabolic disease onset, researchers herein investigated the prospective correlation of 2 anxiety facets, neuroticism and worry, with cardiometabolic risk (CMR) trajectories for 4 decades.
From an ongoing adult male cohort, 1,561 men were included.
In 1975, the Eysenck Personality Inventory‐Short Form neuroticism scale and a Worries Scale were completed by the healthy men (mean age, 53 years [SD, 8.4 years]).
At every 3 to 5 years, assessment of seven CMR biomarkers was done.
From age 33 to 65 years, there was an increase in CMR at 0.8 markers per decade, at which point men had an average of 3.8 high‐risk markers; this was followed by a slower increase of 0.5 markers per decade.
Elevated CMR was recorded across time in correlation with higher neuroticism and worry levels; there were 13% and 10% greater risks, respectively, with having ≥ 6 high‐risk CMR markers, adjusting for potential confounders.
Overall findings suggest association of higher anxiety levels with stable differences in CMR by middle adulthood, that are maintained into older ages.
Deteriorations in cardiometabolic health may occur earlier in life among anxious individuals and a stable trajectory of heightened risk remains into older ages in these people.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries